Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.10.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Product sales $ 1,169 $ 589 $ 3,378 $ 1,192
Operating cost and expense        
Cost of product sales 6,453 3,140 16,489 5,671
Research and development cost 967 1,367 3,645 6,538
General and administrative expense 2,174 1,925 7,862 4,897
Impairment charge 2,411
Total operating expense 9,594 6,432 27,996 19,517
Loss from operations (8,425) (5,843) (24,618) (18,325)
Other income and expense        
Interest expense (919) (454) (2,225) (1,250)
Interest and other income 81 7 123 28
Total other expense, net (838) (447) (2,102) (1,222)
Loss before income tax expense (9,263) (6,290) (26,720) (19,547)
Income tax expense (2) (2)
Net loss $ (9,263) $ (6,290) $ (26,722) $ (19,549)
Weighted average shares outstanding, basic and diluted 38,779,710 20,265,020 32,553,939 19,732,372
Basic and diluted net loss per share $ (0.24) $ (0.31) $ (0.82) $ (0.99)